04.05.2021 HAEMATO AG  DE000A289VV1

DGAP-Adhoc: HAEMATO AG proposes dividend payment


 

DGAP-Ad-hoc: HAEMATO AG / Key word(s): Dividend/Payout
HAEMATO AG proposes dividend payment

04-May-2021 / 15:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad hoc of HAEMATO AG:

HAEMATO AG proposes dividend payment

The Supervisory Board of HAEMATO AG approved the Executive Board's proposal for the appropriation of profits at today's balance sheet meeting. The Executive Board and Supervisory Board will therefore propose a dividend of EUR 1.00 per dividend-bearing share at the Annual General Meeting to be held on July 13, 2021.

About HAEMATO:

HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of its business activities is on the trading of high-priced special pharmaceuticals (with a therapeutic focus on cancer, HIV and other chronic diseases) as well as the development and distribution of medical products and own brands, particularly in the field of "aesthetic medicine".

HAEMATO AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

Key figures of the HAEMATO AG share:

Subscribed capital: EUR 5,299,307

Listed share class: Ordinary bearer shares

ISIN: DE000A289VV1

WKN: A289VV

Stock exchange symbol: HAEK




Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
[email protected]

04-May-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany
Phone: +49 (0)30 897 30 86 70
Fax: +49 (0)30 897 30 86 79
E-mail: [email protected]
Internet: www.haemato.ag
ISIN: DE000A289VV1
WKN: A289VV
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange
EQS News ID: 1192406

 
End of Announcement DGAP News Service

1192406  04-May-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1192406&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 289,86 274,12 197,84 238,33 285,04 248,14 282,00
EBITDA1,2 11,27 9,96 1,90 3,31 12,64 9,66 12,40
EBITDA-Marge3 3,89 3,63 0,96 1,39 4,43 3,89
EBIT1,4 9,42 8,50 -18,68 1,63 11,16 8,30 11,40
EBIT-Marge5 3,25 3,10 -9,44 0,68 3,92 3,35 4,04
Jahresüberschuss1 6,98 6,28 -1,17 -4,83 6,53 8,19 6,90
Netto-Marge6 2,41 2,29 -0,59 -2,03 2,29 3,30 2,45
Cashflow1,7 -8,35 0,56 -2,76 14,67 14,05 19,73 0,00
Ergebnis je Aktie8 3,20 2,70 -0,50 -1,02 1,35 1,57 1,34
Dividende8 3,00 1,00 0,00 0,00 1,10 1,20 3,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Harry Haseloff

INVESTOR-INFORMATIONEN
©boersengefluester.de
Haemato
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A289VV 16,700 - 87,33
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,44 15,54 0,67 8,40
KBV KCV KUV EV/EBITDA
0,61 4,43 0,35 6,85
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,20 0,70 4,19 18.07.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
31.05.2023 31.08.2023 16.11.2023 17.05.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-28,37% -26,14% -38,15% -9,24%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu HAEMATO AG  ISIN: DE000A289VV1 können Sie bei EQS abrufen


Gesundheit , A289VV , HAEK , XETR:HAEK